Neurobiology of L-DOPAergic systems

Progress in Neurobiology

Volumn 49, Issue 5, 1996, Pages 415-454

  Misu, Yoshimi ^a   Goshima, Yoshio ^a   Ueda, Hiroshi ^a   Okamura, Hitoshi ^b  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; BETA ADRENERGIC RECEPTOR; DOPA; DOPAMINE RECEPTOR; GLUTAMIC ACID; LEVODOPA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CATECHOLAMINERGIC SYSTEM; NEUROTRANSMITTER RELEASE; NONHUMAN; PARKINSON DISEASE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; REVIEW;

EID: 0030219943     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/0301-0082(96)00025-1     Document Type: Article

References (237)

1. B receptors differentially regulate striatal acetylcholine release in vivo. Neurosci. Lett. 160:1993;126-130.
2. Anton R., Kordower J.H., Maidment N.Y., Manaster J.S., Kane D.J., Rabizaden S., Schueller S.B., Yang J., Rabizaden S., Edwards R.H., Markham C.H., Bredesen D.E. Neural-targeted gene therapy for rodent and primate hemiparkinsonism. Expl Neurol. 127:1994;207-218.
3. Arai N., Misugi K., Goshima Y., Misu Y. Evaluation of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mouse model for parkinsonism. Brain Res. 515:1990;57-63.
4. Arnt J., Hyttel J., Perregaard J. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats. Eur. J. Pharmacol. 133:1987;137-145.
5. Bartholini G., Bates H.M., Burkard W.P., Pletscher A. Increase of cerebral catecholamines by 3,4-dihydroxyphenylalanine after inhibition of peripheral decarboxylase. Nature. 215:1967;852-853.
6. Bartholini G., Constantinidis J., Puig M., Tissot R., Pletscher A. The stereoisomers of 3,4-dihydroxyphenylserine as precursor of norepinephrine. J. Pharmacol. expl Ther. 193:1975;523-532.
7. Beltramo M., Krieger M., Tillet Y., Thibault J., Calas A., Mazzi V., Franzoni M.F. Immunolocalization of aromatic L-amino acid decarboxylase in goldfish (Carassius auratus) brain. J. Comp. Neurol. 343:1994;209-227.
8. Berger B., Verney C., Gaspar P., Febvret A. Transient expression of tyrosine hydroxylase immunoreactivity in some neurons of the rat neocortex during postnatal development. Develop. Brain Res. 23:1985;141-144.
9. Bharucha N.E., Stokes L., Schoenberg B.S., Ward C., Ince S., Nutt J.G., Eldridge R., Calne D.B., Mantel N., Duvoisin R. A case-control study of twin pairs discordant for Parkinson's disease: a search for environmental risk factors. Neurology. 36:1986;284-288.
10. Birkmayer W., Hornykiewicz O. Der L-2,3-dioxyphenylalanin (= DOPA)-Effekt bei der Parkinson-Akinese. Wien. Klin. Wochenschr. 73:1961;787-788.
11. Björklund, A. and Lindvall, O. (1984) Dopamine-containing system in the CNS. In: Handbook of Chemical Neuroanatomy, Vol. 2. Classical Transmitter in the CNS, Part 1, pp. 55-122. Eds A. Bjöklund and T. Hökfelt. Elsevier: Amsterdam.
12. Blin J., Bonnet A., Agid Y. Does levodopa aggravate Parkinson's disease? Neurology. 38:1988;1410-1416.
13. 2 dopamine receptors in 6-OHDA-lesioned rats receiving foetal ventral mesencephalic grafts and chronic treatment with L-DOPA and carbidopa. Brain Res. 582:1992;299-311.
14. Blunt S.B., Jenner P., Marsden C.D. Suppressive effect of L-DOPA on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6-hydroxydopamine. Mov. Disord. 8:1993;129-133.
15. Bousquet P., Feldman J., Bloch R., Schwartz J. Evidence for a neuromodulatory role of GABA at the first synapse of the baroreceptor reflex pathway. Effects of GABA derivatives injected into the NTS. Naunyn-Schmiedebergs Arch. Pharmacol. 319:1982;168-171.
16. Brannan T., Martinez-Tica J., Yahr M.D. Catechol-O-methyltransferase inhibition increases striatal L-dopa and dopamine: an in vivo study in rats. Neurology. 42:1992;683-685.
17. Bunney B.S., Aghajanian G.K., Roth R.H. Comparison of effects of L-DOPA, amphetamine and apomorphine on firing rate of rat dopaminergic neurons. Nature (New Biol.). 245:1973;123-125.
18. Carboni E., Tanda G., Di Chiara G. Extracellular striatal concentrations of endogenous 3,4-dihydroxyphenylalanine in the absence of a decarboxylase inhibitor: a dynamic index of dopamine synthesis in vivo. J. Neurochem. 59:1992;2230-2236.
19. 2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: a neurophysiological study. Brain Res. 400:1987;205-218.
20. Carlsson A., Lindqvist M., Magnusson T. 3,4,-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature. 180:1957;1200.
21. Catelli J.M., Sved A.F. Enhanced pressor response to GABA in the nucleus tractus solitarii of the spontaneously hypertensive rat. Eur. J. Pharmacol. 151:1988;243-248.
22. Cedarbaum J.M., Gandy S.E., McDowell F.H. "Early" initiation of levodopa treatment does not promote the development of motor response fluctuations, dyskinesia, or dementia in Parkinson's disease. Neurology. 41:1991;622-629.
23. 3H]AMPA binding in rat striatum. Neurosci. Lett. 132:1991;55-58.
24. Chang W.Y., Webster R.A. Effects of 3-O-methyl dopa on L-DOPA-facilitated synthesis and efflux of dopamine from rat striatal slices. Br. J. Pharmacol. 116:1995;2637-2640.
25. Chan-Palay V., Zäborszky L., Köhler C., Goldstein M., Palay S.L. Distribution of tyrosine-hydroxylase immunoreactive neurons in the hypothalamus of rats. J. comp. Neurol. 227:1984;467-496.
26. Chalmers J.P., Petty M.A., Reid J.L. Participation of adrenergic and noradrenergic neurones in central connections of arterial baroreceptor reflexes in the rat. Circ. Res. 45:1979;516-522.
27. Cheng, N.-N., Maeda, T., Kume, T., Kaneko, S., Kohchiyama, H., Akaike, A., Goshima, Y. and Misu, Y. Differential neurotoxicity induced by L-DOPA and dopamine on cultured striatal neurons, unpublished data.
28. Ciriello J. Brainstem projections of aortic baroreceptor afferent fibers in the rat. Neurosci. Lett. 36:1983;37-42.
29. Clarke P.B.S., Kumar R. Characterization of the locomotor stimulant action of nicotine in tolerant rats. Br. J. Pharmacol. 80:1983;587-594.
30. Cohen G. Monoamine oxidase, hydrogen peroxide and Parkinson's disease. Adv. Neurol. 45:1987;119-125.
31. Cooper D.R., Marrel C., Van de Waterbeemd H., Testa B., Jenner P., Marsden C.D. L-DOPA esters as potential prodrugs; behavioural activity in experimental models of Parkinson's disease. J. Pharm. Pharmacol. 39:1987;627-635.
32. Curtis L., Lees A.J., Stern G.M., Marmot M.G. Effect of L-DOPA on course of Parkinson's disease. Lancet. 2:1984;211-212.
33. Dahlström A., Fuxe K. Evidence of the existence of monoamine containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons Acta Physiol. Scand. 62(Suppl. 232):1964;1-55.
34. Doba N., Reis D.J. Role of central and peripheral adrenergic mechanisms in neurogenic hypertension produced by brainstem lesions in rat. Circ. Res. 34:1974;293-301.
35. During M.J., Naegele J.R., O'Malley K.L., Geller A.I. Long-term behavioural recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science. 266:1994;1399-1403.
36. Ehringer H., Hornykiewicz O. Verteilung von Noradrenaline und Dopamine (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin. Wochenschr. 38:1960;1236-1239.
37. 2 receptor interactions in the MPTP-treated marmoset. Neurosci. Lett. 142:1992;1-4.
38. 2+-dependent phosphorylation. Nature. 302:1983;830-832.
39. Falck B., Hillarp N.Å., Thieme G., Torp A. Fluorescesce of catecholamines and related compounds condensed with formaldehyde. J. Histochem. Cytochem. 10:1962;348-354.
40. Gaspar P., Berger B., Febvret A., Vigny A., Krieger-Poulet M., Borri-Voltattorni C. Tyrosine hydroxylase-immuno-reactive neurons in the human cerebral cortex: a novel catecholaminergic group? Neurosci. Lett. 80:1987;257-262.
41. Geffard M., Buijs R.M., Seguela P., Pool C.W., Moal M.L. First demonstration of highly specific and sensitive antibodies against dopamine. Brain Res. 294:1984;161-165.
42. Gershanik O., Heikkila R.E., Duvoisin R.C. Behavioral correlations of dopamine receptor activation. Neurology. 33:1983;1489-1492.
43. Gilman A.G. G protein: transducers of receptor-generated signals. Ann. Rev. Biochem. 56:1987;615-649.
44. Giorguieff-Chesselet M.F., Kemel M.L., Wandscheer D., Glowinski J. Regulation of dopamine release by presynaptic nicotinic receptors in rat striatal slices: effect of nicotine in a low concentration. Life Sci. 25:1979;1257-1262.
45. 3H]DOPA in various regions of the brain J. Neurochem. 13:1966;655-669.
46. Glowinski J., Iversen L.L., Axelrod J. Storage and synthesis of norepinephrine in the reserpine-treated rat brain. J. Pharmacol. expl Ther. 151:1966;385-399.
47. Godwin-Austen R.B., Lee P.N., Marmot M.G., Stern G.M. Smoking and Parkinson's disease. J. Neurol. Neurosurg. Psychiat. 45:1982;577-581.
48. Goshima Y., Kubo T., Misu Y. Autoregulation of endogenous epinephrine release via presynaptic adrenoceptors in the rat hypothalamic slice. J. Pharmacol. expl Ther. 235:1985;248-253.
49. Goshima Y., Kubo T., Misu Y. Biphasic actions of L-DOPA on the release of endogenous noradrenaline and dopamine from rat hypothalamic slices. Br. J. Pharmacol. 89:1986;229-234.
50. Goshima Y., Kubo T., Misu Y. Transmitter-like release of endogenous 3,4-dihydroxyphenylalanine from rat striatal slices. J. Neurochem. 50:1988;1725-1730.
51. Goshima Y., Misu Y., Arai N., Misugi K. Nanomolar L-DOPA facilitates release of dopamine via presynaptic β-adrenoceptors: comparative studies on the actions in striatal slices from control and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mice, an animal model for Parkinson's disease. Japan. J. Pharmacol. 55:1991;93-100.
52. 2-adrenoceptors under essentially complete inhibition of L-aromatic amino acid decarboxylase in rat hypothalamic slices. Japan. J. Pharmacol. 53:1990;47-56.
53. Goshima Y., Nakamura S., Misu Y. L-Dihydroxyphenylalanine methyl ester is a potent competitive antagonist of the L-dihydroxyphenylalanine-induced facilitation of the evoked release of endogenous norepinephrine from rat hypothalamic slices. J. Pharmacol. expl Ther. 258:1991;466-471.
54. Goshima Y., Nakamura S., Ohno K., Misu Y. Picomolar concentrations of L-DOPA stereoselectively potentiate activities of presynaptic β-adrenoceptors to facilitate the release of endogenous noradrenaline from rat hypothalamic slices. Neurosci. Lett. 129:1991;214-216.
55. 2+-dependent and tetrodotoxin-sensitive release of endogenous glutamate from rat striatal slices. Brain Res. 617:1993;167-170.
56. 2+-dependent and tetrodotoxin-sensitive basal L-glutamate release in intact striata and its augmentation in 6-OHDA-lesioned striata of conscious rats, unpublished data.
57. Goshima Y., Ueda H., Misu Y. Therapeutic and adverse effects of L-DOPA. Nanomolar L-DOPA induces basal L-glutamate release in intact striata and its augmentation in 6-OHDA-lesioned striata of awake rats. Japan. J. Pharmacol. 68(Suppl. I):1996;30P.
58. Graham D.G., Tiffany S.M., Bell W.R., Gutnecht W.F. Autooxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine and related compounds towards C1300 neuroblastoma cells in vitro. Mol. Pharmacol. 14:1978;644-653.
59. Greenamyre J.T. Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's disease. J. Neur. Transm. 91:1993;255-269.
60. Guyenet P.G., Filtz T.M., Donaldson S.R. Role of excitatory amino acids in rat vagal and sympathetic baroreflexes. Brain Res. 407:1987;272-284.
61. Halliwell B. Oxidants and the central nervous system: some functional questions. Acta Neurol. Scand. 126:1989;23-33.
62. Hardy S.G.P. Anatomical data supporting the concept of prefrontal influences upon hypothalamo-medullary relays in the rat. Neurosci. Lett. 169:1994;17-20.
63. Hefti F., Melamed E. L-DOPA's mechanism of action in Parkinson's disease. Trends Neurosci. 3:1980;229-231.
64. Hefti F., Melamed E., Bhawan J., Wurtman R.J. Long-term administration of L-DOPA does not damage dopaminergic neurons in the mouse. Neurology. 31:1981;1194-1195.
65. Helke C.J., Niederer A.J. Studies on the coexistence of substance P with other putative transmitters in the nodose and petrosal ganglia. Synapse. 5:1990;144-151.
66. Herman J.-P., Abrous N.D. Dopaminergic neural grafts after fifteen years: results and perspectives. Progr. Neurobiol. 44:1994;1-35.
67. Hess E.J., Wilson M.C. Tottering and leaner mutations perturb transient developmental expression of tyrosine hydroxylase in embryologically distinct Purkinje cell. Neuron. 6:1991;123-132.
68. Hirai K., Katayama Y., Misu Y. L-DOPA induces concentration-dependent facilitation and inhibition of presynaptic acetylcholine release in the guinea-pig submucous plexus. Brain Res. 18:1996;105-111.
69. Hoehn M.M.M. Parkinson's disease: progression and mortality. Adv. Neurol. 45:1986;457-461.
70. Hökfelt, T., Johansson, O. and Goldstein, M. (1984) Central catecholamine neurons as revealed by immunohistochemistry with special reference to adrenaline neurons. In: Handbook of Chemical Neuroanatomy, Vol. II, Classical Transmitters in the CNS, pp. 157-276. Eds A. Björklund and T. Hökfelt. Elsevier: New York.
71. Hökfelt T., Johansson O., Fuxe K., Goldstein M., Park D. Immunohistochemical studies on the localization and distribution of monoamine neuron systems in the rat brain. I. Tyrosine hydroxylase in the mes- and diencephalon Med. Biol. 54:1976;427-453.
72. Hökfelt T., Johansson O., Fuxe K., Goldstein M., Park D. Immunohistochemical studies on the localization and distribution of monoamine neuron systems in the rat brain. 2. Tyrosine hydroxylase in the telencephalon. Med. Biol. 55:1977;21-40.
73. Hunter L.W., Rorie D.K., Tyce G.M. Dihydroxyphenylalanine and dopamine are released from portal vein together with noradrenaline and dihydroxyphenylglycol during nerve stimulation. J. Neurochem. 59:1992;972-982.
74. Hyman C., Hofer M., Barde Y.-A., Juhasz M., Yancopoulos G.D., Squinto S.P., Lindsay R.M. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature. 350:1991;230-232.
75. Inagaki C., Tanaka C. Characteristics of enzymic decarboxylation of L-threo-3,4-dihydroxyphenylserine using hog renal L-aromatic amino acid decarboxylase. Biochem. Pharmacol. 27:1978;1081-1086.
76. 1 protein in the striatum of hemi-dopaminergic lesioned rats. Neurosci. Lett. 175:1994;107-110.
77. Iversen, L.L. (1967) The Uptake and Storage of Noradrenaline in Sympathetic Nerves, pp. 157-168. Cambridge University Press: London.
78. Jackson D.M., Jenkins O.F., Ross S.B. The motor effects of bromocriptine - a review. Psychopharmacology. 95:1988;433-446.
79. Jaeger C.B., Ruggiero D.A., Albert V.R., Park D.H., Jon T.H., Reis D.J. Aromatic L-amino acid decarboxylase in the rat brain: immunocytochemical localization in neurons of the brain stem. Neuroscience. 11:1984;691-713.
80. Jiao S., Gurevich V., Wolff J.A. Long-term correction of rat model of Parkinson's disease by gene therapy. Nature. 362:1993;450-453.
81. Karasawa N., Isomura G., Nagatsu I. Production of specific antibody against L-DOPA and its ultrastructural localization of immunoreactivity in the house-shrew (Suncus murinus) lateral habenular nucleus. Neurosci. Lett. 143:1992;267-270.
82. Kato T., Karai N., Katsuyama M., Nakamura M., Katsube J. Studies on the activity of L-threo-3,4-dihydroxyphenylserine (L-DOPS) as a catecholamine precursor in the brain. Comparison with that of L-DOPA. Biochem. Pharmacol. 36:1987;3051-3057.
83. Katz D.M., Markey K.A., Goldstein M., Black I.B. Expression of catecholaminergic characteristics by primary sensory neurons in the normal adult rat in vivo. Proc. natl Acad. Sci. U.S.A. 80:1983;3526-3530.
84. Kihara M., Misu Y., Kubo T. Release by electrical stimulation of endogenous glutamate, γ-aminobutyric acid, and other amino acids from slices of the rat medulla oblongata. J. Neurochem. 52:1989;261-267.
85. Kirshner N. Uptake of catecholamines by a particulate fraction of the adrenal medulla. J. Biol. Chem. 237:1962;2311-2317.
86. Kiss J.Z., Mezey E. Tyrosine hydroxylase in magnocellular neurosecretory neurons: response to physiological manipulations. Neuroendocrinology. 43:1986;519-525.
87. Kitahama K., Mons N., Okamura H., Jouvet M., Geffard M. Endogenous L-DOPA, its immunoreactivity in neurons of midbrain and its projection field in the cat. Neurosci. Lett. 95:1988;47-52.
88. Kitahama K., Okamura H., Goldstein M., Nagatsu I., Berod A., Jouvet M. A new group of tyrosine hydroxylase-immunoreactive neurons in the cat thalamus. Brain Res. 478:1989;156-160.
89. Köhler C., Everitt B.J., Pearson J., Goldstein M. Immunohistochemical evidence for a new group of catecholamine-containing neurons in the basal forebrain of the monkey. Neurosci. Lett. 37:1983;161-166.
90. Komori K., Uesaka S., Yamaoka H., Fujita K., Yamaoka K., Naitoh H., Kuroda M., Karasawa N., Ito T., Karasawa Y., Nagatsu I. Identification of L-DOPA immunoreactivity in some neurons in the human mesencephalic region: a novel DOPA neuron group? Neurosci. Lett. 157:1993;13-16.
91. Koshimura K., Ohue T., Akiyama Y., Itoh A., Miwa S. L-DOPA administration enhances exocytotic dopamine release in vivo in the rat striatum. Life Sci. 51:1992;747-755.
92. Kristensen E.W., Chinnow S.L., Montreuil R.S., Tyce G.M. Precursors and metabolites of norepinephrine in sympathetic ganglia of the dog. J. Neurochem. 54:1990;1782-1790.
93. 2-adrenoceptor-mediated modulation of the aortic baroreceptor reflex in the nucleus tractus solitarii of the rat. Brain Res. 526:1990;313-317.
94. Kubo T., Kihara M. Evidence for the presence of GABAergic and glycine-like systems responsible for cardiovascular control in the nucleus tractus solitarii of the rat. Neurosci. Lett. 74:1987;331-336.
95. Kubo T., Kihara M. Blood pressure modulation by substance P in the rat nucleus tractus solitarius. Brain Res. 413:1987;379-383.
96. Kubo T., Kihara M. Evidence of N-methyl-D-aspartate receptor-mediated modulation of the aortic baroreceptor reflex in the rat nucleus tractus solitarii. Neurosci. Lett. 87:1988;69-74.
97. Kubo T., Kihara M. N-methyl-D-aspartate receptors mediate tonic vasodepressor control in the caudal ventrolateral medulla of the rat. Brain Res. 451:1988;366-370.
98. Kubo T., Kihara M. Evidence for γ-aminobutyric acid receptor-mediated modulation of the aortic baroreceptor reflex in the nucleus tractus solitarii of the rat. Neurosci. Lett. 89:1988;156-160.
99. Kubo T., Kihara M. Unilateral blockade of excitatory amino acid receptors in the nucleus tractus solitarii produces an inhibition of baroreflexes in rats. Naunyn-Schmiedebergs Arch. Pharmacol. 343:1991;317-322.
100. Kubo T., Kihara M., Misu Y. Ipsilateral but not contralateral blockade of excitatory amino acid receptor in the caudal ventrolateral medulla inhibits aortic baroreceptor reflex in rats. Naunyn-Schmiedebergs Arch. Pharmacol. 343:1991;46-51.
101. Kubo T., Misu Y. Pharmacological characterization of the α-adrenoceptors responsible for a decrease of blood pressure in the nucleus tractus solitarii of the rat. Naunyn-Schmiedebergs Arch. Pharmacol. 319:1981;120-125.
102. Kubo T., Nagura J., Kihara M., Misu Y. Cardiovascular effects of L-glutamate and γ-aminobutyric acid injected into the rostral ventrolateral medulla in normotensive and spontaneously hypertensive rats. Arch. Int. Pharmacodyn. 279:1986;150-161.
103. Kubo T., Yue J.-L., Goshima Y., Nakamura S., Misu Y. Evidence for L-DOPA systems responsible for cardiovascular control in the nucleus tractus solitarii of the rat. Neurosci. Lett. 140:1992;153-156.
104. Kurlan R. Practical therapy of Parkinson's disease. Semin. Neurol. 7:1987;160-166.
105. Lafon-Cazal M., Pietri S., Culcasi M., Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature. 364:1993;535-537.
106. Lange K.W., Riederer P. Glutamatergic drugs in Parkinson's disease. Life Sci. 55:1994;2075-2607.
107. Lawrence A.J., Jarrott B. L-glutamate as a neurotransmitter at baroreceptor afferents: evidence from in vivo microdialysis. Neuroscience. 58:1994;585-591.
108. Leone C., Gordon F.J. Is L-glutamate a neurotransmitter of baroreceptor information in the nucleus of the tractus solitarius? J. Pharmacol. expl Ther. 250:1989;953-962.
109. Li Y.W., Halliday G.M., Joh T.H., Geffen L.B., Blessing W.W. Tyrosine hydroxylase-containing neurons in the supraoptic and paraventricular nuclei of the adult human. Brain Res. 461:1988;75-86.
110. Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathways neurologic disorders. New Eng. J. Med. 330:1994;613-622.
111. Lloyd K.G., Davidson L., Hornykiewicz O. The neurochemistry of Parkinson's disease: effect of L-DOPA therapy. J. Pharmacol. expl Ther. 195:1975;453-464.
112. Luft F.C., Demmert G., Rohmeiss P., Unger T. Baroreceptor reflex effect on sympathetic nerve activity in stroke-prone spontaneously hypertensive rats. J. Auton. nerv. Syst. 17:1986;199-209.
113. Matsushita, N., Goshima, Y., Miyamae, T. and Misu, Y. Regional distribution of L-DOPA as a neurotransmitter candidate in the rat brain, unpublished data.
114. Meister B., Hökfelt T., Steinbusch H.W.M., Skagerberg G., Lindvall O., Geffard M., Joh T.H., Cuello A.C., Goldstein M. Do tyrosine hydroxylase-immunoreactive neurons in the ventrolateral arcuate nucleus produce dopamine or only L-DOPA? J. Chem. Neuroanat. 1:1988;59-64.
115. Misu Y., Goshima Y. Is L-DOPA an endogenous neurotransmitter? Trends Pharmacol. Sci. 14:1993;119-123.
116. Misu Y., Goshima Y., Kubo T. Biphasic actions of L-DOPA on the release of endogenous dopamine via presynaptic receptors in rat striatal slices. Neurosci. Lett. 72:1986;194-198.
117. 2+-dependently endogenous 3,4-dihydroxyphenylalanine from rat striatal slices. Brain Res. 520:1990;334-337.
118. Misu Y., Goshima Y., Ueda H., Kubo T. Presynaptic inhibitory dopamine receptors on noradrenergic nerve terminals: analysis of biphasic actions of dopamine and apomorphine on the release of endogenous norepinephrine in rat hypothalamic slices. J. Pharmacol. expl Ther. 235:1985;771-777.
119. Misu Y., Kubo T. Presynaptic β-adrenoceptors. Med. Res. Rev. 6:1986;197-225.
120. 2+-dependent and tetrodotoxin-sensitive release of glutamate from striata of conscious rat. J. Neurochem. Suppl. 65:1995;S154.
121. Misu Y., Ueda H., Goshima Y. Neurotransmitter-like actions of L-DOPA. Adv. Pharmacol. 32:1995;427-459.
122. Misu Y., Yue J.-L., Goshima Y. L-DOPA systems for blood pressure regulation in the lower brainstem. Neurosci. Res. 23:1995;147-158.
123. A systems for cardiovascular control in the rat nucleus tractus solitarii. In: GABA: Receptors, Transporters and Metabolism, pp. 115-121. Eds C. Tanaka and N.G. Bowery. Birkhäuser Verlag: Basel.
124. Misu Y., Yue J.-L., Okumura Y., Nishihama M., Okumura F. Endogenous L-DOPA but not glutamate or GABA is released by aortic nerve and baroreceptor stimulation in the nucleus tractus solitarii (NTS) of rats. Japan. J. Pharmacol. 64(Suppl. I):1994;342.
125. Miura M., Reis D.J. Termination and secondary projections of carotid sinus nerve in the cat brain stem. Am. J. Physiol. 217:1969;142-153.
126. Miyamae, T., Goshima, Y. and Misu, Y. (1996a) L-DOPAergic pre- and post-synaptic components in the caudal ventrolateral medulla (CVLM) play essential roles in neurotransmission via baroreceptor-aortic depressor nerve-nucleus tractus solitarii-CVLM-relay of rats. The 8th International Catecholamine Symposium, Asilomar, U.S.A.
127. Miyamae T., Yue J.-L., Goshima Y., Misu Y. Depressor action of L-threo-dihydroxyphenylserine in the rat nucleus tractus solitarii. Eur. J. Pharmacol. 300:1996;105-108.
128. Miyamae T., Yue J.-L., Okumura Y., Goshima Y., Misu Y. Loss of tonic neuronal activity to release L-DOPA in the caudal ventrolateral medulla of spontaneously hypertensive rats. Neurosci. Lett. 198:1995;37-40.
129. Mons N., Danel N., Geffard M. Visualization of L-dihydroxyphenylalanine in rat brain by using specific antibodies. Brain Res. 451:1988;403-407.
130. Mons N., Geffard M. Specific antisera against the catecholamines: L-3,4-dihydroxyphenylalanine, dopamine, noradrenaline and octopamine tested by an enzyme-linked immunosorbent assay. J. Neurochem. 48:1987;1826-1833.
131. Mons N., Tison F., Geffard M. Existence of L-DOPA immunoreactive neurons in the rat preoptic area and anterior hypothalamus. Neuroendocrinology. 51:1990;425-428.
132. Morrison S.F., Ernsberger P., Milner T.A., Callaway J., Gong A., Reis D.J. A glutamate mechanism in the intermediolateral nucleus mediates sympathoexcitatory responses to stimulation of the rostral ventrolateral medulla. Progr. Brain Res. 81:1989;159-169.
133. Nagatsu I., Kondo Y., Inagaki S., Karasawa N., Kato T., Nagatsu T. Immunofluorescent studies on tyrosine hydroxylase: application for its axoplasmic transport. Acta Histochem Cytochem. 10:1977;494-499.
134. +-evoked release of 3,4-dihydroxyphenylalanine from the striatum in conscious rats studied by microdialysis. J. Neurochem. 58:1992;270-275.
135. Nakamura S., Goshima Y., Yue J.-L., Miyamae T., Misu Y. Transmitter-like 3,4-dihydroxyphenylalanine is tonically released by nicotine in striata of conscious rats. Eur. J. Pharmacol. 222:1992;75-80.
136. Nakamura S., Goshima Y., Yue J.-L., Miyamae T., Misu Y. Endogenously released DOPA is probably relevant to nicotine-induced increases in locomotor activities of rats. Japan. J. Pharmacol. 62:1993;107-110.
137. 2 receptor-mediated locomotor activities of conscious rats. Neurosci. Lett. 170:1994;22-26.
138. Naoi M., Nagatsu T. Inhibition of monoamine oxidase by 3,4-dihydroxyphenylserine. J. Neurochem. 47:1986;604-607.
139. Narabayashi H., Kondo Y., Hayashi A., Suzuki T., Nagatsu T. L-threo-3,4-dihydroxyphenylserine treatment for akinesia and freezing of parkinsonism. Proc. Japan. Acad. 57 Ser. B:1981;353-354.
140. Newcomer T.A., Rosengerg P.A., Aizenman E. TOPA quinone, a kainate-like agonist and excitotoxin, is generated by a catecholaminergic cell line. J. Neurosci. 15:1995;3172-3177.
141. Ng K.Y., Chase T.N., Colburn R.W., Kopin I.J. L-DOPA-induced release of cerebral monoamines. Science. 170:1970;76-77.
142. Ng K.Y., Chase T.N., Colburn R.W., Kopin I.J. Dopamine: stimulation-induced release from central neurons. Science. 172:1971;487-489.
143. Nishihama M., Yue J.-L., Goshima Y., Okumura F., Misu Y. Electrical stimulation of posterior hypothalamus induces transmitter-like release of endogenous L-DOPA from rostral ventrolateral medulla of anesthetized rats. Japan. J. Pharmacol. 67(Suppl. I):1995;266.
144. Nishihama, M., Goshima, Y., Miyamae, T., Okumura, F. and Misu, Y. Evidence for an L-DOPA relay from the posterior hypothalamic nucleus to the rostral ventrolateral medulla and for its involvement in cardiopressor control in anesthetized rats, unpublished data.
145. Nishino N., Fujii Y., Kondo M., Shuntoh H., Fujiwara H., Tanaka C. Effects of L-threo-3,4-dihydroxyphenylserine on efflux of monoamines and acetylcholine in guinea pig brain. J. Pharmacol. expl Ther. 242:1987;621-628.
146. Numao Y., Saito M., Terui N., Kumada M. Physiological properties of the three subtypes constituting the aortic nerve-renal sympathetic reflex in rabbits. J. Auton. nerv. Syst. 9:1983;361-380.
147. Ogawa N., Asanuma M., Kondo Y., Kawada Y., Yamamoto M., Mori A. Differential effects of chronic L-DOPA treatment on lipid peroxidation in the mouse brain with or without pretreatment with 6-hydroxydopamine. Neurosci. Lett. 171:1994;55-58.
148. Okamoto K., Aoki K. Development of a strain of spontaneously hypertensive rats. Japan. Circ. J. 27:1963;282-293.
149. Okamura H., Kitahama K., Mons N., Ibata Y., Jouvet M., Geffard M. L-DOPA-immunoreactive neurons in the rat hypothalamic tuberal region. Neurosci. Lett. 95:1988;42-46.
150. Okamura, H., Kitahama, K., Mons, N., Matsumoto, Y., Ibata, Y. and Geffard, M. (1990a) Heterogeneous distribution of L-DOPA immunoreactivity in dopaminergic neurons of the rat midbrain. In: Basic, Clinical, and Therapeutic Aspects of Alzheimer's and Parkinson's Diseases, Vol. 1, pp. 423-426. Eds T. Nagatsu, A. Fisher and M. Yoshida. Plenum Press: New York.
151. Okamura H., Kitahama K., Nagatsu I., Geffard M. Comparative topography of dopamine and tyrosine hydroxylase-immunoreactive neurons in the rat arcuate nucleus. Neurosci. Lett. 95:1988;347-353.
152. Okamura H., Kitahama K., Raynaud B., Borri-Voltattorni C., Nagatsu I., Weber M. Immunocytochemistry of aromatic L-amino acid decarboxylase in the rat preoptic area and anterior hypothalamus, with special reference to tyrosine hydroxylase immunocytochemistry. Biogen. Amines. 7:1990;351-361.
153. Okamura H., Kitahama K., Raynaud B., Nagatsu I., Borri-Voltattorni C., Weber M. Aromatic L-amino acid decarboxylase (AADC)-immunoreactive cells in the tuberal region of the rat hypothalamus. Biomed. Res. 9:1988;261-267.
154. Okamura H., Murakami S., Chihara K., Nagatsu I., Ibata Y. Coexistence of growth hormone releasing factor-like and tyrosine hydroxylase-like immunoreactivities in neurons of the rat arcuate nucleus. Neuroendocrinology. 41:1985;177-179.
155. Okamura, H., Tanate, M. and Ibata, Y. Immunoelectron microscopic observation of L-DOPA-immunoreactive terminals in the median eminence, unpublished data.
156. 2+-dependent and tetrodotoxin-sensitive release of endogenous glutamate from striata of conscious rats. Japan. J. Pharmacol. 67(Suppl. I):1995;232.
157. Olanow C.W. A radical hypothesis for neurodegeneration. Trends Neurosci. 16:1993;439-444.
158. Olney J.W. Excitotoxic amino acids and neuropsychiatric disorders. Ann. Rev. Pharmacol. Toxicol. 30:1990;47-71.
159. Olney J.W., Zorumski C.F., Stewart G.R., Price M.T., Wang G., Labruyere J. Excitotoxicity of L-DOPA and 6-OH-DOPA: implications for Parkinson's and Huntington's disease. Expl Neurol. 108:1990;269-272.
160. O'Neill M.F., Dourish C.T., Iversen S.D. Evidence for an involvement of D1 and D2 dopamine receptors in mediating nicotine-induced hyperactivity in rats. Psychopharmacology. 104:1991;343-350.
161. Patel K.P., Kline R.L., Mercer P.F. Noradrenergic mechanisms in the brain and peripheral organs of normotensive and spontaneously hypertensive rats at various ages. Hypertension. 3:1981;682-690.
162. Paul M.L., Graybiel A.M., David J.-C., Robertson H.A. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J. Neurosci. 12:1992;3729-3742.
163. +-evoked release of transmitter amino acids investigated by microdialysis. J. Neurochem. 52:1989;1823-1829.
164. Pawloski-Dahm C., Gordon F.J. Evidence for a kynurenate-insensitive glutamate receptor in nucleus tractus solitarii. Am. J. Physiol. 262:1992;H1611-H1615.
165. Perry T.L., Wee Yong V., Ito M., Foulks J.G., Wall R.A., Godin D.V., Clavier R.M. Nigrostriatal dopaminergic neurons remain undamaged in rats given high doses of L-DOPA and carbidopa chronically. J. Neurochem. 43:1984;990-993.
166. Ponzio F., Achilli G., Perego C., Rinaldi G., Algeri S. Does acute L-DOPA increase active release of dopamine from dopaminergic neurons? Brain Res. 273:1983;45-51.
167. Price J., Mudge A.W. A subpopulation of rat dorsal root ganglion neurones is catecholaminergic. Nature. 301:1983;241-243.
168. Rajput A.H., Offord K.P., Beard C.M., Kurland L.T. Epidemiology of Parkinsonism: incidence, classification, and mortality. Ann. Neurol. 16:1984;278-282.
169. Rapier C., Lunt G.G., Wonnacott S. Stereoselective nicotine-induced release of dopamine from striatal synaptosomes: concentration dependence and repetitive stimulation. J. Neurochem. 50:1988;1123-1130.
170. Reis D.J., Granata A.R., Perrone M.H., Talman W.T. Evidence that glutamic acid is the neurotransmitter of baroreceptor afferents terminating in the nucleus tractus solitarius (NTS). J. Auton. nerv. Syst. 3:1981;321-334.
171. Reis D.J., Ruggiero D.A., Morrison S.F. The C1 area of the rostral ventrolateral medulla oblongata. Am. J. Hypertens. 2:1989;363S-374S.
172. 2 dopamine agonists on turning behaviour in rats. Brain Res. 384:1986;387-390.
173. Ross C.A., Ruggiero D.A., Joh T.H., Park D.H., Reis D.J. Rostral ventrolateral medulla: selective projections to the thoracic autonomic cell column from the region containing C1 adrenaline neurons. J. comp. Neurol. 228:1984;168-185.
174. Ross C.A., Ruggiero D.A., Park D.H., Joh T.H., Sved A.F., Fernandez-Pardal J., Saavedra J.M., Reis D.J. Tonic vasomotor control by the rostral ventrolateral medulla; effect of electrical or chemical stimulation of the area containing C1 adrenaline neurons on arterial pressure, heart rate, and plasma catecholamines and vasopressin. J. Neurosci. 4:1984;474-494.
175. Ross C.A., Ruggiero D.A., Reis D.J. Afferent projections to cardiovascular portions of the nucleus of the tractus solitarius in the rat. Brain Res. 223:1981;402-408.
176. Ross C.A., Ruggiero D.A., Reis D.J. Projections from the nucleus tractus solitarii to the rostral ventrolateral medulla. J. comp. Neurol. 242:1985;511-534.
177. Roth R.H. CNS dopamine autoreceptors: distribution, pharmacology, and function. Ann. NY Acad. Sci. 430:1984;27-53.
178. Sahakian B.J., Carlson K.R., De Girolami U., Bhawan J. Functional and structural consequences of long-term dietary L-DOPA treatment in mice. Commun. Psychopharmacol. 4:1980;169-176.
179. Sakai M., Fuji T., Karasawa N., Arai R., Nagatsu I. Enhanced expression of tyrosine hydroxylase and aromatic L-amino acid decarboxylase in cerebellar Purkinje cells of mouse after hyperosmotic stimuli. Neurosci. Lett. 194:1995;142-144.
180. B receptor agonists and antagonists. Brain Res. 630:1993;28-31.
181. Sapru H.N., Gonzalez E., Krieger A.J. Aortic nerve stimulation in the rat: cardiovascular and respiratory responses. Brain Res. Bull. 6:1981;393-398.
182. Sapru H.N., Krieger A.J. Carotid and aortic chemoreceptor function in the rat. J. appl. Physiol. 42:1977;344-348.
183. 2-adrenoceptor- but not facilitatory angiotensin II receptor-mediated modulation of noradrenaline release from rat hypothalamic slices. Japan. J. Pharmacol. 62:1993;119-122.
184. Sato K., Ueda H., Okumura F., Misu Y. Supersensitization of intrastriatal dopamine receptors involved in opposite regulation of acetylcholine release in Parkinson's model rats. Neurosci. Lett. 173:1994;59-62.
185. 3 agonist, on acetycholine release during striatal microdialysis in conscious rats. Brain Res. 655:1994;233-236.
186. Scigliano G., Musicco M., Soliveri P., Piccolo I., Girotti F., Caraceni T. Mortality associated with early and late levodopa therapy initiation in Parkinson's disease. Neurology. 40:1990;265-269.
187. Shaw K.M., Lees A.J., Stern G.M. The impact of treatment with levodopa on Parkinson's disease. Q. J. Med. 195:1980;283-293.
188. Skagerberg G., Meister B., Hökfelt T., Lindvall O., Goldstein M., Joh T., Cuello A.C. Studies on dopamine-, tyrosine hydroxylase- and aromatic L-amino acid decarboxylase-containing cells in the rat diencephalon: comparison between formaldehyde-induced histofluorescence and immunofluorescence. Neuroscience. 24:1988;605-620.
189. Slominski A., Pruski D. L-DOPA binding sites in rodent melanoma cell. Biochim. Biophys. Acta. 1139:1992;324-328.
190. Smith J.K., Barron K.W. Cardiovascular effects of L-glutamate and tetrodotoxin microinjected into the rostral and caudal ventrolateral medulla in normotensive and spontaneously hypertensive rats. Brain Res. 506:1990;1-8.
191. Smith T.S., Parker W.D. Jr., Bennett J.P. Jr. L-DOPA increases nigral production of hydroxyl radicals in vivo: potential L-DOPA toxicity? NeuroReport. 5:1994;1009-1011.
192. Starke K. Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Biochem. Pharmacol. 77:1977;1-124.
193. Sun M.-K., Guyenet P.G. Hypothalamic glutamatergic input to medullary sympathoexcitatory neurons in rats. Am. J. Physiol. 251:1986;R798-R810.
194. Sved A.F., Curtis J.T. Amino acid neurotransmitters in nucleus tractus solitarius: an in vivo microdialysis study. J. Neurochem. 61:1993;2089-2098.
195. Sved A.F., Salter J.N. Glutamate release in the nucleus tractus solitarius is not affected by baroreceptor afferents. Soc. Neurosci. Abstr. 16:1990;218.
196. B receptors in nucleus tractus solitarius to increase blood pressure. Brain Res. 526:1990;235-240.
197. B receptors in the nucleus tractus solitarius modulates the baroreceptor reflex. Brain Res. 592:1992;37-42.
198. Talman W.T. Kynurenic acid microinjected into the nucleus tractus solitarii of rat blocks the arterial baroreflex but not responses to glutamate. Neurosci. Lett. 102:1989;247-252.
199. Talman W.T., Perrone M.H., Reis D.J. Evidence for L-glutamate as the neurotransmitter of baroreceptor afferent nerve fibers. Science. 209:1980;813-815.
200. Tanaka M., Okamura H., Kawakami F., Mons N., Geffard M., Ibata Y. L-DOPA-immunoreactivity in hypothalamic magnocellular neurons of hypothalamo-neurohypophysial system. Neurosci. Res. 16:1991;S29.
201. Tison F., Mons N., Geffard M., Henry P. Immunohistochemistry of endogenous L-DOPA in the rat posterior hypothalamus. Histochemistry. 93:1990;655-660.
202. Tison F., Mons N., Rouet-Kamara S., Geffard M., Henry P. Endogenous L-DOPA in the rat dorsal vagal complex: an immunocytochemical study by light and electron microscopy. Brain Res. 497:1989;260-270.
203. Uchida K., Tsuzaki N., Nagatsu T., Kohsaka S. Tetrahydrobiopterin-dependent functional recovery in 6-hydroxy-dopamine-treated rats by intracerebral grafting of fibroblasts transfected with tyrosine hydroxylase cDNA. Develop. Neurosci. 14:1992;173-180.
204. Uda K., Okamura H., Murakami S., Nagatsu I., Ibata Y. Regional distribution of tyrosine hydroxylase immunoreactive neuronal elements in the rat and monkey spinal cord. Biogen. Amines. 4:1987;153-162.
205. Ueda H., Goshima Y., Kubo T., Misu Y. Involvement of epinephrine in the presynaptic beta adrenoceptor mechanism of norepinephrine release from rat hypothalamic slices. J. Pharmacol. expl Ther. 232:1985;507-512.
206. 2-adrenoceptors of endogenous noradrenaline and dopamine release from slices of rat hypothalamus. Life Sci. 33:1983;371-376.
207. Ueda H., Nozaki M., Satoh M. Multiple opioid receptors and GTP-binding proteins. Comp. Biochem. Physiol. 98c:1991;157-169.
208. Ueda H., Sato K., Okumura F., Inoue A., Nakata Y., Misu Y. Supersensitization of neurochemical responses by L-DOPA and dopamine receptor agonists in the striatum of experimental Parkinson's disease model rats. Biomed. Pharmacother. 49:1995;169-177.
209. Ueda H., Sato K., Okumura F., Misu Y. L-DOPA inhibits spontaneous acetylcholine release from the striatum of experimental Parkinson's model rats. Brain Res. 698:1995;213-216.
210. Ueda H., Uno S., Harada J., Kobayashi I., Katada T., Ui M., Satoh M. Evidence for receptor-mediated inhibition of intrinsic activity of GTP-binding protein Gi1 and Gi2, but not Go in reconstitution experiments. FEBS Lett. 266:1990;178-182.
211. Ui K., Nishihara S., Sakuma M., Togashi S., Ueda R., Miyata Y., Miyake T. Newly established cell lines from Drosophila larval CNS expressed neural specific characteristics. In vitro Cell Develop. Biol. 30A:1994;209-216.
212. Ui-Tei K., Nishihara S., Sakuma M., Matsuda K., Miyake T., Miyata Y. Chemical analysis of neurotransmitter candidates in clonal cell lines from Drosophila central nervous system. I. ACh and L-DOPA Neurosci. Lett. 174:1994;85-88.
213. Urbanski R.W., Sapru H.N. Evidence for a sympathoexcitatory pathway from the nucleus tractus solitarii to the ventrolateral medullary pressor area. J. Auton. nerv. Syst. 23:1988;161-174.
214. Urbanski R.W., Sapru H.N. Putative neurotransmitters involved in medullary cardiovascular regulation. J. Auton. nerv. Syst. 25:1988;181-193.
215. Velasco F., Velasco M., Cuevas H.R., Jurado J., Olvera J., Jimenez F. Autologous adrenal medullary transplants in advanced Parkinson's disease with particular attention to the selective improvement in symptoms. Stereoact. Funct. Neurosurg. 57:1991;195-212.
216. Verberne A.J.M., Young N.A., Louis W.J. Impairment of inhibitory cardiopulmonary vagal reflexes in spontaneously hypertensive rats. J. Auton. nerv. Syst. 23:1988;63-68.
217. Versteeg D.H.G., Palkovits M., Van Der Gugten J., Wijnen H.L.J.M., Smeets G.W.M., De Jong W. Catecholamine content of individual brain regions of spontaneously hypertensive rats (SH-rats). Brain Res. 112:1976;429-434.
218. 2 agonist effects. Science. 236:1987;719-722.
219. 2 coactivation induces potentiated responses. Brain Res. 405:1987;234-246.
220. Westerink B.H.C., Van Es T.P., Spaan S.J. Effects of drugs interfering with dopamine and noradrenaline biosynthesis on the endogenous 3,4-dihydroxyphenylalanine levels in the rat brain. J. Neurochem. 39:1982;44-51.
221. Westerink B.H.C., Hofsteede R.M., Tuntler J., de Vries J.B. Use of calcium antagonism for the characterization of drug-evoked dopamine release from the brain of conscious rats determined by microdialysis. J. Neurochem. 52:1989;722-729.
222. 3H-dopamine by slices of rat striatum. Naunyn-Schmied. Arch. Pharmacol. 292:1976;279-287.
223. Willette R.N., Punnen S., Krieger A.J., Sapru H.N. Interdependence of rostral and caudal ventrolateral medullary areas in the control of blood pressure. Brain Res. 321:1984;169-174.
224. Wurtman R.J., Hefti F., Melamed E. Precursor control of neurotransmitter synthesis. Pharmacol. Rev. 32:1981;315-335.
225. Yahr M.D. Parkinson's disease. The L-DOPA era. Adv. Neurol. 60:1993;11-17.
226. Yamori Y., Lovenberg W., Sjoerdsma A. Norepinephrine metabolism in brainstem of spontaneously hypertensive rats. Science. 170:1970;544-546.
227. Yoshida M., Kondo Y., Karasawa N., Yamada K., Takagi I., Nagatsu I. Immunohistocytochemical localization of catecholamine-synthesizing enzymes in suprarenal, superior cervical and nodose ganglia of dogs. Acta Histochem. Cytochem. 14:1981;588-595.
228. Young W.S., Warden M., Mezey E. Tyrosine hydroxylase mRNA is increased by hyperosmotic stimuli in the paraventricular and supraoptic nuclei. Neuroendocrinology. 46:1987;439-444.
229. Yue J.-L., Goshima Y., Misu Y. Transmitter-like L-3,4-dihydroxyphenylalanine tonically functions to mediate vasodepressor control in the caudal ventrolateral medulla of rats. Neurosci. Lett. 159:1993;103-106.
230. Yue J.-L., Goshima Y., Miyamae T., Misu Y. Evidence for L-DOPA relevant to modulation of sympathetic activity in the rostral ventrolateral medulla of rats. Brain Res. 629:1993;310-314.
231. A systems for cardiovascular control in the rat nucleus tractus solitarii, unpublished data.
232. Yue J.-L., Goshima Y., Nakamura S., Misu Y. L-DOPA-like regulatory actions of L-threo-3,4-dihydroxyphenylserine on the release of endogenous noradrenaline via presynaptic receptors in rat hypothalamic slices. J. Pharm. Pharmacol. 44:1992;990-995.
233. 2 receptor-mediated locomotor activities of conscious rats. Neurosci. Lett. 170:1994;107-110.
234. Yue J.-L., Okamura H., Goshima Y., Nakamura S., Geffard M., Misu Y. Baroreceptor-aortic nerve-mediated release of endogenous L-3,4-dihydroxyphenylalanine and its tonic function in the nucleus tractus solitarii of rats. Neuroscience. 62:1994;145-161.
235. Yue J.-L., Okumura Y., Goshima Y., Miyamae T., Ueda H., Misu Y. L-DOPA releases endogenous GABA - a possible modulatory role of GABA in the L-DOPA system for the cardiovascular control in the nucleus tractus solitarii of rats. Japan. J. Pharmacol. 67(Suppl. I):1995;233.
236. Yue J.-L., Okumura Y., Miyamae T., Ueda H., Misu Y. Altered tonic L-3,4-dihydroxyphenylalanine systems in the nucleus tractus solitarii and the rostral ventrolateral medulla of spontaneously hypertensive rats. Neuroscience. 67:1995;95-106.
237. Zandberg P., De Jong W., De Wied D. Effect of catecholamine-receptor stimulating agents on blood pressure after local application in the nucleus tractus solitarii of the medulla oblongata. Eur. J. Pharmacol. 55:1979;43-56.